Provided by Tiger Trade Technology Pte. Ltd.

Sensei Biotherapeutics, Inc.

13.85
0.0000
Volume:- -
Turnover:- -
Market Cap:18.56M
PE:-0.10
High:13.85
Open:13.85
Low:13.85
Close:13.85
52wk High:36.76
52wk Low:7.45
Shares:1.34M
Float Shares:810.90K
Volume Ratio:2.41
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-142.7282
EPS(LYR):-16.7239
ROE:-195.26%
ROA:-20.79%
PB:0.11
PE(LYR):-0.83

Loading ...

Sensei Biotherapeutics initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
May 29

Sensei Biotherapeutics Initiated at Buy by LUCID CAPITAL MARKETS

Dow Jones
·
May 29

Sensei Biotherapeutics Updates 2026 Board Reconstitution Plans

TIPRANKS
·
May 23

Sensei Biotherapeutics delays Karen Vousden board appointment to late 2026

Reuters
·
May 23

Sensei Biotherapeutics Initiated at Buy by Citigroup

Dow Jones
·
May 22

Sensei Biotherapeutics initiated with a Buy at Citi

TIPRANKS
·
May 22

Sensei Biotherapeutics Sets Vote on Series B Conversion

TIPRANKS
·
May 22

Sensei Biotherapeutics prices $200 million PIPE at $13.85 per share

Reuters
·
May 22

Sensei Biotherapeutics initial beneficial ownership filing shows Millennium Management stake

Reuters
·
May 16

Sensei Biotherapeutics Q1 EPS $(131.45) Misses $(0.62) Estimate

Benzinga Earnings
·
May 15

Sensei Biotherapeutics FY26 Q1 net loss widens to $170.24 million

Reuters
·
May 15

Press Release: Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
May 15

Sensei Biotherapeutics doses first patient in PIKTOR Phase 1b/2 breast cancer trial

Reuters
·
May 05

Sensei Biotherapeutics Doses First Patient in Phase 1B/2 Trial of Piktor in Hr+/Her2- Advanced Breast Cancer

THOMSON REUTERS
·
May 05

Sensei Biotherapeutics Inc expected to post a loss of 62 cents a share - Earnings Preview

Reuters
·
May 01

Sensei Biotherapeutics Inc - Registers 24.9 Mln Shares for Resale by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Apr 28

Leerink Partners Initiates Coverage on Sensei Biotherapeutics With Outperform Rating, $50 PT

MT Newswires Live
·
Apr 20

Sensei Biotherapeutics Announces Leadership and Board Transitions

TIPRANKS
·
Apr 17

Sensei Biotherapeutics announces annual shareholder meeting webcast

Reuters
·
Apr 17

Sensei Biotherapeutics to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 09